Court revives lawsuit challenging FDA's anti-ivermectin messaging

A federal appeals court has revived a lawsuit against the FDA, filed by three doctors, claiming that the agency overstepped its boundaries by aggressively discouraging the use of ivermectin for COVID-19 treatment. The doctors argue that the FDA's messaging harmed their reputations and that the agency should inform, not prescribe. The court found that there was a basis for the lawsuit to proceed, stating that the FDA has the authority to inform but not endorse or advise. Ivermectin has been a subject of debate, with some doctors prescribing it for COVID-19 treatment, while critics dismiss it as "cattle" or "horse medication." The drug is approved for human use to treat parasites and other conditions, but self-administering it can be dangerous.